CLINICAL ROLE -
Ashley Gallagher is an assistant editor at Pharmacy Times®. She graduated from St. Bonaventure University in 2020 in journalism and mass communications. Previously, she worked as a pharmacy technician for a retail chain.
Study: Non-Health Care Settings Spread C. Difficile Bacteria
Investigators from the University of Houston find that 45% of the positive samples were from the soles of shoes.
Read More
Study: NK Cells Are More Effective Than CAR-T Treatment for Multiple Myeloma
CAR-NK therapies are also shown to have fewer adverse reactions, and 25% of mice that were treated remained disease-free.
4 of 5 Individuals Who Had COVID-19 Recover Sense of Smell and Taste
Those who are younger than aged 40 years tend to regain these senses at higher rates than those who are older.
CDC, FDA Discuss the Effectiveness of COVID-19 Boosters
A town hall meeting with representatives from the agencies emphasized the effectiveness and likelihood of getting a third dose of the vaccine.
NY Pharmacy Rescue Package Bill Proposes Regulations on Fair Drug Pricing
New legislation in New York state seeks to address flaws in prescription drug distribution system.
Use of Constipation Drugs Show Improved Cognitive Function
In a study, individuals who were taking prucalopride had better memory tests and fMRI scans indicating enhanced brain activity in relation to cognition.
Antibody for Symptomatic COVID-19 Prophylaxis Submitted for Emergency Use Authorization
AZD7442 (AstraZeneca), a long-acting antibody combination, reduced the risk of developing symptomatic COVID-19 by 77% compared to placebo.
FDA Grants EUA for a Combined COVID-19 and Flu Home Testing Kit
Labcorp’s collection kit can simultaneously detect the coronavirus and influenza A/B in individuals aged 2 years and older, and results can be determined in 1 to 2 days.
Synthetic Opioid Shows Immune System Response to Decrease Colon Inflammation
Study results show KNT-127 is a promising therapeutic option and enhances the anti-inflammatory response.
Pregnant Women Benefit from Getting COVID-19 Vaccination
With the Delta variant, there was an increase in coronavirus-related hospitalizations by more than one-third among these individuals.
AXS-12 Phase 3 Trial Enrolls First Individual
Axsome Therapeutics continues to explore its narcolepsy drug after the FDA granted it orphan drug designation.
Hand Sanitization and Washing Could Be Harming Health Care Workers
In a Pharmacy Times® interview, Jessica Hui, a researcher and pediatric allergist at National Jewish Health, discussed how increased hand hygiene may be harming the hands of healthcare workers.
Individuals With Psoriasis Are Hesitant to Get Vaccinated for COVID-19
The main factors behind the vaccine hesitancy are the potential adverse effects post-vaccination and effect on their autoimmune conditions, as well as lack of trial data, an analysis shows.
FDA Grants Priority Review for Cabotegravir to Prevent HIV
The medication receives the approval after it was shown to be more effective than daily tenofovir disoproxil fumarate with emtricitabine tablets.
FDA Approves Livmarli for Treatment of Alagille Syndrome for Those 1 Year and Older
The agency has given the greenlight to maralixibat after the ICONIC study combined with 5 years of supportive studies that demonstrated the reduction of pruritis.
Steroid Nasal Sprays Can Lessen the Development of Severe COVID-19 Infections
Individuals who used intranasal corticosteroids prior to being infected were about 22% less likely to be hospitalized from severe COVID-19 than those who did not.
Phase 3 Study Results Show Xarelto Bests Aspirin With Fewer Blood Clots in Children
Rivaroxaban (Xarelto, Janssen) demonstrates a lower incidence of bleeding events in pediatric patients.
COVID-19 May Be More Deadly for Individuals with Type 2 Diabetes
T2D is associated with a higher mortality risk linked to the coronavirus than individuals with T1D.
Weight Loss Can Reverse Cardiovascular Risk of Obesity
Study shows that shedding pounds potentially decreases the risk of diabetes, dyslipidemia, and high blood pressure.
Keytruda Meets Endpoints in KEYNOTE Trial, Treatment of Hepatocellular Carcinoma
The medication has met the criteria of overall survival for individuals with this type of liver cancer who were previously treated with sorafenib, Merck says.
Levetiracetam Improves Cognitive Function for Some Individuals with Alzheimer Disease
Patients with senile dementia who have silent epileptic activity show improvement when taking this medication.
Older Women and Younger Men Are More Likely to Have Uncontrolled Hypertension
Study results presented at an American Heart Association conference show that 34% of individuals have high blood pressure.
Extended-Release Narcolepsy Drug Shows Promise in Once-a-Night Dose
Investigators at Stanford Medicine find that 72% of individuals who took the highest dose of ON-SXB were considered much or very much improved.
Study: Antibiotic Regimen Can Treat Round Pneumonia in Pediatric Patients
Treatment of round pneumonia should be followed up with a 2-view chest X-ray weeks later.
IVIG Therapy May Help Treat Drug-Induced Erythroderma
An intravenous immunoglobulin option along with glucocorticoids could be effective in fighting drug-induced erythroderma for patients with AIDS.
New Antibiotics Can Be Useful as Treatment for Community-Acquired Pneumonia
Study shows Lefamulin, omadacycline, ceftaroline, delafloxacin are beneficial in treating community-acquired pneumonia.
FDA Approves Jakafi to Treat Chronic GVHD
The overall response rate of ruxolitinib at week 24 was 49.7% compared with 25.6% for the best available therapy treatment for graft-versus-host-disease.
Moderna COVID-19 Vaccine Remains Effective for 5.3 Months After Second Dose
It demonstrated 93.2% efficacy 14 days afterward and greater than 90% for 4 or more months.
Individuals Aged 50 Years or Older Say Health and Vaccinations Improve Quality of Life
Survey results from Kantar show that people rate these factors more important than an active family life and financial security in terms of well-being.
FDA Approves Opzelura as Treatment for Atopic Dermatitis
In clinical trials, the majority of patients with atopic dermatitis treated with ruxolitinib had clear or almost clear skin.